In-person and Telephonic Shared Decision-making Visits for People Considering Lung Cancer Screening An Assessment of Decision Quality
To the Editor:
The decision to undergo lung cancer screening (LCS) is complex, and a shared decision-making (SDM) visit is essential. Although the Centers for Medicare & Medicaid Services requires an in-person visit, this approach may not be feasible for certain providers and patients due to constrained resources and logistical considerations. 1 We undertook the present study to determine the effect of an SDM visit delivered by two different methods on patient satisfaction and decisional conflict.
Subjects and Methods
This analysis was a prospective observational study. Eligible participants were recruited from the Medical University of South Carolina and the Ralph H. Johnson Veterans Affairs Hospital. Participants completed a self-administered baseline survey; underwent an SDM visit, which utilized a decision aid, either in person or over the telephone; and then completed a follow-up telephone survey 1 month later (e-Appendix 1).
The effects of the SDM intervention were examined based on constructs from the Ottawa Decision Support Framework (Fig 1) . Patient-provider communication, cultural beliefs and values, perceived benefits, and harms of LCS, decision impact, decision quality, and decision action were measured according to the survey.
Results
A total of 137 subjects (91%) completed the study and were included in the final analysis (Fig 2) . There was no difference in age, race, socioeconomic status, or education between groups, although there were more male participants in the telephonic SDM group. Most participants (n ¼ 104 [75.9%]) were in the highest [ Correspondence ] 
Discussion
To our knowledge, this report is the first regarding decision quality following an SDM visit for LCS, and it adds to existing literature in several ways. First, using either method of SDM, decision quality and decision impact were high. Second, irrespective of their decision for or against screening, patients were highly satisfied, with little decisional conflict. Finally, after undergoing a structured SDM visit that provided individual risk for developing lung cancer, 88% choose to be screened.
Given that only 4% of eligible patients in the United States were screened for lung cancer in 2015 with little change in the subsequent 2 years, 2,3 novel approaches for patient outreach should be considered.
Although the Centers for Medicare & Medicaid Services mandates an in-person SDM visit prior to LCS, it is unclear whether primary care providers understand the nuances of LCS, including eligibility, benefits, potential harms, and smoking cessation counseling. 1 Conducting an SDM visit over the telephone has the potential to improve logistics and convenience for patients.
Conclusions
An LCS SDM visit that includes individual risk prediction and counseling regarding LCS results in high decisional quality and impact, regardless of the method of delivery. These findings suggest that alternative delivery methods could be used to increase access to shared-decision making for LCS as it is implemented across the United States. In a recent issue of CHEST (August 2018), Jones et al 1 concluded there were significant "inaccurate descriptions of brain death when compared to the national guidelines" in a cross-sectional analysis of readily accessible public websites on the Internet. The authors used the national guidelines as the reference standard and measure of accuracy of information, although these guidelines have been assigned the weakest level of supportive scientific evidence, "U" (ie, unknown or unproven). 2 It seems that FOR RELATED ARTICLE, SEE PAGE 21
